SAN ANTONIO, July 09, 2025--bioAffinity Technologies' CyPath® Lung detects Stage 1A lung cancer when imaging was inconclusive ...

SAN ANTONIO, May 20, 2025--Pulmonologist Gordon Downie, MD, PhD, joins bioAffinity Technologies as Chief Medical Officer.

The critically acclaimed rock group--consisting of vocalist Gordon Downie who passed away from brain cancer in 2017, guitarist Paul Langlois, guitarist Rob Baker, bassist Gord Sinclair, and ...

“Given her risk factors and the fact that I’ve been following her with CT scans, this finding was very worrisome,” Gordon H. Downie, MD, PhD, Director of the Pulmonary Nodule Clinic at Titus ...

Dr. Gordon Downie shares case-based evidence demonstrating how CyPath® Lung improves diagnostic confidence and guides care in high-risk patients SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity ...

bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer May 20, 2025 9:00 AM ET bioAffinity Technologies, Inc. (BIAF) Q1: 2025-05-15 Earnings Summary ...

Dr. Gordon Downie shares case-based evidence demonstrating how CyPath® Lung improves diagnostic confidence and guides care in high-risk patients bioAffinity Technologies, Inc. (Nasdaq: BIAF ...

The critically acclaimed rock group--consisting of vocalist Gordon Downie who passed away from brain cancer in 2017, guitarist Paul Langlois, guitarist Rob Baker, ...

bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer Provided by Business Wire May 20, 2025, 1:00:00 PM.

Dr. Gordon Downie shares case-based evidence demonstrating how CyPath® Lung improves diagnostic confidence and guides care in high-risk patients ...